{"disease":{"id":"conjunctivitis-allergic","name":"conjunctivitis allergic"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02555761","title":"Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in Korea","phase":"","overall_status":"COMPLETED","enrollment_count":3423,"lead_sponsor_name":"Allergan","has_results":false},{"nct_id":"NCT05191186","title":"Documentation of Efficacy of Intralymphatic Allergen Immunotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT06063044","title":"Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children","phase":"","overall_status":"COMPLETED","enrollment_count":407,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT02161146","title":"AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Allergan","has_results":true},{"nct_id":"NCT03850626","title":"Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients","phase":"","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"Leti Pharma GmbH","has_results":false},{"nct_id":"NCT01437982","title":"A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":false},{"nct_id":"NCT07096440","title":"Noninterventional Study on Tolerability and Safety of One Strength Updosing With Novo-Helisen Depot House Dust Mites","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":105,"lead_sponsor_name":"Allergopharma GmbH & Co. KG","has_results":false},{"nct_id":"NCT04299399","title":"Corneal Biomechanical Changes of Allergic Conjunctivitis","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT03963947","title":"Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Alfons Malet i Casajuana","has_results":false},{"nct_id":"NCT03709121","title":"A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Aldeyra Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03604718","title":"Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata","phase":"","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Probelte Pharma S.L.U.","has_results":false},{"nct_id":"NCT04532710","title":"Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Marinomed Biotech AG","has_results":false},{"nct_id":"NCT04071249","title":"Validation of a Combined Symptom and Medication Score in Patients Suffering From Allergic Rhinoconjunctivitis","phase":"","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"ClinNovis GmbH","has_results":false},{"nct_id":"NCT03758456","title":"HAL-MRE1 Subcutaneous Immunotherapy in Ragweed Allergic Patients First-in-human","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"HAL Allergy","has_results":false},{"nct_id":"NCT00311844","title":"A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT07385495","title":"OJO-miR: microRNA Expression in Allergic Conjunctivitis.","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Instituto de Oftalmología Fundación Conde de Valenciana","has_results":false},{"nct_id":"NCT03375775","title":"Evaluation of Subcutaneous Immunotherapy Towards Pollen in Children","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Karolinska Institutet","has_results":false},{"nct_id":"NCT04207697","title":"Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander","phase":"","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Probelte Pharma S.L.U.","has_results":false},{"nct_id":"NCT03379311","title":"A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Allakos Inc.","has_results":false},{"nct_id":"NCT03682965","title":"Texan Allergy & Sinus Center Mountain Cedar Intra-Lymphatic Immunotherapy Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"Christopher Thompson, MD","has_results":true},{"nct_id":"NCT04874714","title":"Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Inmunotek S.L.","has_results":false},{"nct_id":"NCT04037891","title":"Topical rVA576 for Treatment of Atopic Keratoconjunctivitis","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"AKARI Therapeutics","has_results":true},{"nct_id":"NCT03038971","title":"Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node Injections","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Woodmont Pharmaceuticals, Inc.","has_results":false}],"total":23},"guidelines":[],"source":"Drug Landscape verified database"}